At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism.
With over 6000 people worldwide and 60 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges.
1957
Served areaWorldwide
Headcount6,000
HeadquartersHans Michelsensgatan 10, 20120 Malmö – Sweden
Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|
Assets | N/A | 13,858,000,000.00 | 14,612,000,000.00 | 16,167,000,000.00 |
Noncurrent Assets | N/A | 9,728,000,000.00 | 10,437,000,000.00 | 11,137,000,000.00 |
Property Plant And Equipment | N/A | 1,282,000,000.00 | 1,454,000,000.00 | 1,802,000,000.00 |
Investment Accounted For Using Equity Method | N/A | 120,000,000.00 | 123,000,000.00 | 132,000,000.00 |
Other Noncurrent Financial Assets | N/A | 134,000,000.00 | 117,000,000.00 | 119,000,000.00 |
Noncurrent Recognised Assets Defined Benefit Plan | N/A | 33,000,000.00 | 238,000,000.00 | 205,000,000.00 |
Noncurrent Finance Lease Receivables | N/A | 21,000,000.00 | 51,000,000.00 | 38,000,000.00 |
Current Assets | N/A | 4,130,000,000.00 | 4,175,000,000.00 | 5,030,000,000.00 |
Inventories | N/A | 1,039,000,000.00 | 1,369,000,000.00 | 1,674,000,000.00 |
Current Trade Receivables | N/A | 1,500,000,000.00 | 1,542,000,000.00 | 1,708,000,000.00 |
Other Current Receivables | N/A | 282,000,000.00 | 209,000,000.00 | 283,000,000.00 |
Current Tax Assets Current | N/A | 71,000,000.00 | 18,000,000.00 | 87,000,000.00 |
Other Current Financial Assets | N/A | 14,000,000.00 | 2,000,000.00 | 0.00 |
Cash and cash equivalents | 662,000,000.00 | 972,000,000.00 | 757,000,000.00 | 949,000,000.00 |
Current Derivative Financial Assets | N/A | 19,000,000.00 | 26,000,000.00 | 45,000,000.00 |
Current Finance Lease Receivables | N/A | 13,000,000.00 | 24,000,000.00 | 21,000,000.00 |
Equity And Liabilities | N/A | 13,858,000,000.00 | 14,612,000,000.00 | 16,167,000,000.00 |
Issued Capital | N/A | 91,000,000.00 | 91,000,000.00 | 91,000,000.00 |
Retained Earnings | N/A | 5,367,000,000.00 | 6,028,000,000.00 | 6,138,000,000.00 |
Other Reserves | N/A | 172,000,000.00 | 766,000,000.00 | 1,395,000,000.00 |
Equity Attributable To Owners Of Parent | N/A | 5,630,000,000.00 | 6,885,000,000.00 | 7,624,000,000.00 |
Noncurrent Liabilities | N/A | 3,014,000,000.00 | 1,238,000,000.00 | 3,922,000,000.00 |
Other Longterm Provisions | N/A | 64,000,000.00 | 71,000,000.00 | 69,000,000.00 |
Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | 37,000,000.00 | 32,000,000.00 | 29,000,000.00 |
Current Liabilities | N/A | 5,214,000,000.00 | 6,490,000,000.00 | 4,621,000,000.00 |
Other Shortterm Provisions | N/A | 75,000,000.00 | 57,000,000.00 | 67,000,000.00 |
Trade And Other Current Payables To Trade Suppliers | N/A | 504,000,000.00 | 614,000,000.00 | 587,000,000.00 |
Current Accruals And Current Deferred Income Including Current Contract Liabilities | N/A | N/A | 1,021,000,000.00 | 942,000,000.00 |
Current Tax Liabilities Current | N/A | 22,000,000.00 | 61,000,000.00 | 106,000,000.00 |
Other Current Financial Liabilities | N/A | 3,051,000,000.00 | 4,177,000,000.00 | 2,322,000,000.00 |
Current Derivative Financial Liabilities | N/A | 32,000,000.00 | 16,000,000.00 | 26,000,000.00 |
Other Current Liabilities | N/A | 293,000,000.00 | 216,000,000.00 | 212,000,000.00 |
Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
---|---|---|---|
Revenue | 9,078,000,000.00 | 9,070,000,000.00 | 9,979,000,000.00 |
Other Income | 7,000,000.00 | 17,000,000.00 | 31,000,000.00 |
Profit Loss From Operating Activities | 866,000,000.00 | 1,077,000,000.00 | 691,000,000.00 |
Finance Income | 5,000,000.00 | 11,000,000.00 | 42,000,000.00 |
Finance Costs | 169,000,000.00 | 98,000,000.00 | 135,000,000.00 |
Other Income Expense From Subsidiaries Jointly Controlled Entities And Associates | 0.00 | -9,000,000.00 | -10,000,000.00 |
Profit Loss Before Tax | 702,000,000.00 | 989,000,000.00 | 597,000,000.00 |
Income Tax Expense Continuing Operations | 175,000,000.00 | 247,000,000.00 | 149,000,000.00 |
Profit (loss) | 526,000,000.00 | 742,000,000.00 | 447,000,000.00 |
Profit Loss Attributable To Owners Of Parent | 526,000,000.00 | 742,000,000.00 | 447,000,000.00 |
Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|
Profit (loss) | N/A | 526,000,000.00 | 742,000,000.00 | 447,000,000.00 |
Adjustments For Finance Costs | N/A | -28,000,000.00 | -4,000,000.00 | 6,000,000.00 |
Adjustments For Decrease Increase In Inventories | N/A | -30,000,000.00 | -232,000,000.00 | -165,000,000.00 |
Adjustments For Depreciation And Amortisation Expense | N/A | N/A | 956,000,000.00 | 1,077,000,000.00 |
Other Adjustments For Noncash Items | N/A | 56,000,000.00 | -2,000,000.00 | -7,000,000.00 |
Interest Paid Classified As Operating Activities | N/A | 101,000,000.00 | 89,000,000.00 | 116,000,000.00 |
Interest Received Classified As Operating Activities | N/A | 5,000,000.00 | 4,000,000.00 | 16,000,000.00 |
Income Taxes Paid Refund Classified As Operating Activities | N/A | 132,000,000.00 | 132,000,000.00 | 233,000,000.00 |
Cash Flows From Used In Operating Activities | N/A | 2,267,000,000.00 | 1,734,000,000.00 | 915,000,000.00 |
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 49,000,000.00 | 19,000,000.00 | 0.00 |
Cash Flows From Used In Investing Activities | N/A | -972,000,000.00 | -695,000,000.00 | -902,000,000.00 |
Proceeds From Borrowings Classified As Financing Activities | N/A | 8,574,000,000.00 | 9,942,000,000.00 | 24,328,000,000.00 |
Repayments Of Borrowings Classified As Financing Activities | N/A | 8,791,000,000.00 | 10,808,000,000.00 | 23,747,000,000.00 |
Payments Of Lease Liabilities Classified As Financing Activities | N/A | 327,000,000.00 | 330,000,000.00 | 377,000,000.00 |
Cash Flows From Used In Financing Activities | N/A | -963,000,000.00 | -1,277,000,000.00 | 136,000,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 332,000,000.00 | -237,000,000.00 | 150,000,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -22,000,000.00 | 22,000,000.00 | 42,000,000.00 |
Cash and cash equivalents | 662,000,000.00 | 972,000,000.00 | 757,000,000.00 | 949,000,000.00 |
Please note that some sums might not add up.
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
20.10.23 | Johan Malmquist | Other | Buy | SEK 1,785,430.00 |
04.09.23 | Karl Joacim Claesson Lindoff | Other | Buy | SEK 1,068,500.00 |
31.08.23 | Dan Frohm | Other | Buy | SEK 340,490.00 |
31.08.23 | Dan Frohm | Other | Buy | SEK 339,178.60 |
10.08.23 | Johan Malmquist | Other | Buy | SEK 2,136,500.00 |
27.04.23 | Jonas Cederhage | Other | Buy | SEK 30,940.00 |
25.04.23 | Jonas Cederhage | Other | Sell | SEK 30,632.00 |
28.02.23 | Marion Gullstrand | Other | Buy | SEK 647,110.00 |
28.02.23 | Maria Nilsson | Other | Buy | SEK 84,323.00 |
28.02.23 | Ingrid Carlsson | Other | Buy | SEK 78,460.00 |
Position Holder | Short Interest in Percent | Date |
---|---|---|
ALCUR FONDER AB | 0.53% | 14.03.24 |
Total | 0.53% |
SE0010468116
LEI549300OWGJPYKC6JF790
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.